Metraipolis › archive › dc_0ed91fc3e377

Cardiovascular Safety of Next-Generation Antibody-Drug Conjugates in HER2-Low and Triple-Negative Breast Cancer: A Narrative Review (2020-2025) — Europe PMC PMID:42382890

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42382890
DOI
10.7759/cureus.109966
License (as archived)
solo-consultazione
Archived
2026-11-01T02:58:52.591Z
SHA-256 of the archived text
077150e75a151e900f94267d2ac066ae0a843380813a4969e4a1c875d4128fe8
Stable URL of this page
https://metraipolis.com/documento/dc_0ed91fc3e377

How to cite

Cardiovascular Safety of Next-Generation Antibody-Drug Conjugates in HER2-Low and Triple-Negative Breast Cancer: A Narrative Review (2020-2025) — Europe PMC PMID:42382890 — Europe PMC (en), https://europepmc.org/article/MED/42382890 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0ed91fc3e377 (Metraipolis archive dc_0ed91fc3e377, sha256 077150e75a151e900f94267d2ac066ae0a843380813a4969e4a1c875d4128fe8)
BibTeX
@misc{dc0ed91fc3e377,
  title = {Cardiovascular Safety of Next-Generation Antibody-Drug Conjugates in HER2-Low and Triple-Negative Breast Cancer: A Narrative Review (2020-2025) — Europe PMC PMID:42382890},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42382890},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0ed91fc3e377; sha256 077150e75a151e900f94267d2ac066ae0a843380813a4969e4a1c875d4128fe8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42382890. Agents can read the archived copy with the MCP tool read_document.